West Michigan Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
West Michigan Advisors's PFE Position: Q2 2026 in Review
West Michigan Advisors increased its Pfizer (PFE) stake by 30% in Q2 2026, buying an estimated $78.1K and bringing the position to 12,820 shares worth $309K. The position accounts for 0.06% of the portfolio, ranked #233.
West Michigan Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $996K in Q1 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- West Michigan Advisors held 12,820 shares of Pfizer worth $309K as of Q2 2026.
- West Michigan Advisors bought 2,984 Pfizer shares in Q2 2026, an estimated $78.1K.
- Pfizer made up 0.06% of West Michigan Advisors's portfolio in Q2 2026, its #233 holding.
- West Michigan Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- West Michigan Advisors's Pfizer position peaked at $996K in Q1 2023.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.